MacroGenics, Inc.
MGNX
$4.62
-$0.24-4.94%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 57.48% | 113.03% | -34.21% | 105.99% | 44.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 57.48% | 113.03% | -34.21% | 105.99% | 44.90% |
| Cost of Revenue | -1.32% | -0.66% | 4.44% | -8.90% | -6.33% |
| Gross Profit | 25.63% | 88.56% | -58.21% | 37.25% | 18.28% |
| SG&A Expenses | -9.40% | -66.79% | -29.77% | -35.51% | -27.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.87% | -26.13% | -4.09% | -14.47% | -11.20% |
| Operating Income | 21.55% | 77.11% | -65.61% | 36.82% | 20.70% |
| Income Before Tax | 10.39% | -3.14% | -70.13% | 35.06% | 21.37% |
| Income Tax Expenses | -- | -182.31% | -- | -- | -- |
| Earnings from Continuing Operations | 10.39% | 8.21% | -70.13% | 34.88% | 21.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.39% | 8.21% | -70.13% | 34.88% | 21.37% |
| EBIT | 21.55% | 77.11% | -65.61% | 36.82% | 20.70% |
| EBITDA | 22.28% | 79.54% | -63.54% | 38.17% | 21.30% |
| EPS Basic | 11.06% | 8.92% | -70.36% | 35.36% | 22.21% |
| Normalized Basic EPS | 11.07% | 70.79% | -70.35% | 35.55% | 22.23% |
| EPS Diluted | 11.06% | 10.30% | -70.36% | 35.36% | 22.21% |
| Normalized Diluted EPS | 11.07% | 70.79% | -70.33% | 35.55% | 22.23% |
| Average Basic Shares Outstanding | 0.77% | 0.79% | 0.78% | 0.75% | 1.08% |
| Average Diluted Shares Outstanding | 0.77% | 0.79% | 0.66% | 0.75% | 1.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |